Replies to post #39711 on RespireRx Pharmaceuticals Inc (RSPI)

[Jumpinjackas]

It's on their website,

In particular, I look forward to discussing preliminary, top-line results of the Company’s recently concluded Phase 2A clinical trial testing the impact of the Company’s proprietary oral ampakine, CX-1739, on opioid-induced respiratory depression.” Dr. Manuso also will discuss the Company’s other product pipeline candidates, including dronabinol, and the Company’s development timeline